2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$306.97-$0.86 (-0.28%)
Price as of Oct 22, 2026 7:50 PM EDT- $6.3BMarket Cap
- 69.63%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$306.97-$0.86 (-0.28%)
LGND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $307.82 | ||
Change | +$8.38 (+2.73%) | ||
Open | $313.00 | ||
High | $315.27 | ||
Low | $305.34 | ||
Previous Close | $314.78 | ||
Volume | 315,135 | ||
30-Day Average Volume | 255,372 | ||
1-Week Change | 6.71% | ||
1-Month Change | 8.52% | ||
1-Year Change | 69.63% | ||
3-Year Change | 504.30% | ||
5-Year Change | 137.80% | ||
Fundamentals | |||
Shares Outstanding | 19.9M | ||
Total Assets | $2.2B | ||
Market Cap | $6.3B | ||
Enterprise Value | $6.6B | ||
Period: QTR TTM FY | |||
Revenue | $37.4M | ||
Net Income | $48.5M | ||
Free Cash Flow | $24.0M | ||
EBIT | $65.9M | ||
EBITDA | $74.1M | ||
Net Working Capital | $1.4B | ||
EPS | $2.22 | ||
Enterprise Value/EBITDA | 89 | ||
Enterprise Value/Revenue | 177 | ||
P/B | 6 | ||
P/E | 142 | ||
PEG | 0 | ||
Price/Free Cash Flow | 262 | ||
Price/Operating Cash Flow | 261 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/02/2010 | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 11/19/2010 | ||
Earnings & Revenue